Adverse events · girls with Turner syndrome who were treated with prepubertal growth hormone
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Rate of symptom relief · women previously treated for endometrial cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Rate of tumour recurrence · women previously treated for endometrial cancer
It is very uncertain whether oestrogen replacement therapy changes rate of tumour recurrence compared with placebo (very low certainty).
1 finding from 1 review
Rate of appearance of a new malignancy · women previously treated for endometrial cancer
It is very uncertain whether oestrogen replacement therapy changes rate of appearance of a new malignancy compared with placebo (very low certainty).
1 finding from 1 review
Rate of survival: overall survival · women previously treated for endometrial cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Progression‐free survival (PSF) · women previously treated for endometrial cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Multiple pregnancy rate · intrauterine insemination (IUI) in women with infertility
Gonadotrophins with anti‐oestrogens showed no clear difference in multiple pregnancy rate per couple compared with gonadotropins alone (low certainty).
1 finding from 1 review
Clinical pregnancy rate · intrauterine insemination (IUI) in women with infertility
It is very uncertain whether gonadotrophins with anti‐oestrogens changes clinical pregnancy rate per couple compared with gonadotropins alone (very low certainty).
1 finding from 1 review
OHSS · intrauterine insemination (IUI) in women with infertility
Gonadotrophins with anti‐oestrogens showed no clear difference in OHSS rate per couple compared with gonadotropins alone (low certainty).
1 finding from 1 review
Venous thromboembolism · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) probably leads to higher venous thromboembolism (DVT or PE) compared with placebo (moderate certainty).
1 finding from 1 review
Venous thrombo‐embolism (DVT or PE): CEE 0.625 mg (moderate dose) · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) showed no clear difference in venous thromboembolism (DVT or PE): CEE 0.625 mg (moderate dose) compared with placebo (moderate certainty).
1 finding from 1 review
Breast cancer · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) showed no clear difference in breast cancer compared with placebo (moderate certainty).
1 finding from 1 review
Gallbladder disease · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) probably leads to higher gallbladder disease compared with placebo (moderate certainty).
1 finding from 1 review
All clinical fractures · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) probably leads to lower all clinical fractures compared with placebo (moderate certainty).
1 finding from 1 review
Coronary events (MI or cardiac death) · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) showed no clear difference in coronary events (MI or cardiac death) compared with placebo (moderate certainty).
1 finding from 1 review
Stroke · relatively healthy postmenopausal women
Oestrogen‐only hormone therapy (HT) probably leads to higher stroke compared with placebo (moderate certainty).
1 finding from 1 review
Intervention not reported
Oestrogen(1 trial; 78 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Oestrogen(1 RCT; 78 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
It is very uncertain whether the intervention changes oestrogen(1 RCT; 78 participants) (very low certainty).
1 finding from 1 review
OR 1.11 [0.03, 44.88]
Studies not reported
Very low
Live birth rate per couple · intrauterine insemination (IUI) in women with infertility
Gonadotropins probably leads to higher live birth rate per couple ‐ all types of infertility compared with anti‐oestrogens (moderate certainty).
1 finding from 1 review
Miscarriage · intrauterine insemination (IUI) in women with infertility
Aromatase inhibitors showed no clear difference in miscarriage rate per couple compared with anti‐oestrogens (low certainty).
1 finding from 1 review